Literature DB >> 10459981

Possible interaction between sildenafil and HIV combination therapy.

R Nandwani, Y Gourlay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10459981     DOI： 10.1016/S0140-6736(99)90041-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir.

Authors:  G J Muirhead; M B Wulff; A Fielding; D Kleinermans; N Buss
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 2.  Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Authors:  G K Dresser; J D Spence; D G Bailey
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

3.  High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.

Authors:  Jason M Cota; Taylor M Benavides; John D Fields; Nathan Jansen; Anuradha Ganesan; Rhonda E Colombo; Jason M Blaylock; Ryan C Maves; Brian K Agan; Jason F Okulicz
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.